Raju Century, MD
Critical Care Medicine · Concord, NCNPI 1700039245
Payments from drug & device makers
What this record shows
20 manufacturers reported payments, led by AstraZeneca at 59.9% of the total. Reporting peaked in 2021 at $2,441 and has fallen 99.1% since, to $22 in 2024.
Across 127 payments — averaging $39.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$570
- Actelion Pharmaceuticals US, Inc.$303
- Boehringer Ingelheim$272
- Genentech USA, Inc.$186
- Mylan Specialty L.p.$162
- plus $508 from 14 others
What the payments were for
- Consulting fees$2,35047%
- Food & beverage$2,63253%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 33 | $2,983 |
| GSK | 29 | $570 |
| Actelion Pharmaceuticals US, Inc. | 9 | $303 |
| Boehringer Ingelheim | 10 | $272 |
| Genentech USA, Inc. | 12 | $186 |
| Mylan Specialty L.p. | 9 | $162 |
| Advanced Respiratory, Inc | 3 | $90 |
| United Therapeutics Corporation | 4 | $79 |
| Philips North America LLC | 3 | $64 |
| Merck | 3 | $50 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Shire North American Group Inc | 2 | $29 |
| Sanofi | 1 | $25 |
| Abiomed | 1 | $22 |
| Insmed, Inc. | 1 | $21 |
| Electromed, Inc. | 2 | $21 |
| Grifols USA, LLC | 1 | $18 |
| Bayer | 1 | $13 |
| Fisher & Paykel Healthcare Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,982 in reported general payments places this provider in the 85th percentile of 190 critical care medicine providers in North Carolina.
See all critical care medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Concord
- Alexis SmithHuntersville$726K
- Rabih BecharaCharlotte$453K
- Ashish KhannaWinston Salem$364K
- Alan HeffnerCharlotte$326K
- Daniel FeinsteinPinehurst$213K
- Daniel FoxRaleigh$133K
- Hassan YousafWinston Salem$97K
- Neil MacintyreDurham$70K
- Andrea MacdonaldRaleigh$67K
- John DotyCharlotte$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.